ProfileOfResearchers

TÃTULO: Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial Full Text
AUTORES: Ravandi, F; Roboz, GJ; Wei, AH; Dohner, H; Pocock, C; Selleslag, D; Montesinos, P; Sayar, H; Musso, M; Figuera Alvarez, A; Safah, H; Tse, W; Sohn, SK; Hiwase, D; Chevassut, T; Pierdomenico, F; La Torre, I; Skikne, B; Bailey, R; Zhong, JH; Beach, CL; Dombret, H; ...Mais
PUBLICAÇÃO: 2021, FONTE: JOURNAL OF HEMATOLOGY & ONCOLOGY, VOLUME: 14, NÚMERO: 1

INDEXADO EM:

Scopus

WOS

TÃTULO: Gastrointestinal events and management strategies for patients with acute myeloid leukemia (AML) in first remission receiving oral azacitidine (Oral-AZA) in the randomized, placebo-controlled, phase 3 QUAZAR AML-001 maintenance trial
AUTORES: Pfeilstocker, M; Ravandi, F; Pocock, C; Selleslag, D; Montesinos, P; Sayar, H; Musso, M; Figuera, A; Safah, H; Tse, W; Sohn, SK; Hiwase, D; Chevassut, T; Pierdomenico, F; La Torre, I; Skikne, B; Beach, CL; Dombret, H;
PUBLICAÇÃO: 2021, FONTE: ONCOLOGY RESEARCH AND TREATMENT, VOLUME: 44

INDEXADO EM:

WOS

TÃTULO: Gastrointestinal Events and Management Strategies for Patients with Acute Myeloid Leukemia (AML) in First Remission Receiving CC-486 Maintenance Therapy in the Randomized, Placebo-Controlled, Phase III QUAZAR AML-001 Trial Full Text
AUTORES: Farhad Ravandi; Christopher Pocock; Dominik Selleslag; Pau Montesinos; Hamid Sayar; Maurizio Musso; Angela F Figuera Alvarez; Hana Safah; William Tse; Sang Kyun Sohn; Devendra Hiwase; Timothy Chevassut; Francesca Pierdomenico; Ignazia La Torre; Barry Skikne; Keshava Kumar; Qian Dong; Beach, CL; Herve Dombret;
PUBLICAÇÃO: 2020, FONTE: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, VOLUME: 20

INDEXADO EM:

WOS

TÃTULO: The QUAZAR AML-001 maintenance trial: Results of a phase III international, randomized, double-blind, placebo-controlled study of oral CC-486 in patients with Acute Myeloid Leukemia (AML) in first remission
AUTORES: Doehner, H; Wei, AH; Pocock, C; Montesinos, P; Dombret, H; Ravandi, F; Sayar, H; Jang, JH; Porkka, K; Selleslag, D; Sandhu, I; Turgut, M; Giai, V; Ofran, Y; Cakar, MK; Botelho de Sousa, AB; Rybka, J; Frairia, C; Borin, L; Beltrami, G; Cermak, J; Pfeilstoecker, M; Thol, F; Feldmann, G; Ossenkoppele, GJ; La Torre, I; Skikne, B; Kumar, K; Dong, Q; Beach, CL; Roboz, GJ; ...Mais
PUBLICAÇÃO: 2020, FONTE: ONCOLOGY RESEARCH AND TREATMENT, VOLUME: 43, NÚMERO: SUPPL 4

INDEXADO EM:

WOS

TÃTULO: High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial
AUTORES: Roelof Willemze; Stefan Suciu; Giovanna Meloni; Boris Labar; Jean Pierre Marie; Constantijn J M Halkes; Petra Muus; Martin Mistrik; Sergio Amadori; Giorgina Specchia; Francesco Fabbiano; Francesco Nobile; Marco Sborgia; Andrea Camera; Dominik L D Selleslag; Francois Lefrere; Domenico Magro; Simona Sica; Nicola Cantore; Meral Beksac; Zwi Berneman; Xavier Thomas; Lorella Melillo; Jose E Guimaraes; Pietro Leoni; Mario Luppi; Maria E Mitra; Dominique Bron; Georges Fillet; Erik W A Marijt; Adriano Venditti; Anne Hagemeijer; Marco Mancini; Joop Jansen; Daniela Cilloni; Liv Meert; Paola Fazi; Marco Vignetti; Silvia M Trisolini; Franco Mandelli; Theo de Witte; ...Mais
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 32, NÚMERO: 3

INDEXADO EM:

Scopus

WOS

TÃTULO: THE SEQUENTIAL COMBINATION OF GEMTUZUMAB OZOGAMICIN AND INTENSIVE CHEMOTHERAPY DOES NOT BENEFIT OLDER PATIENTS WITH UNTREATED AML: RESULTS OF THE EORTC-GIMEMA AML-17 RANDOMIZED TRIAL Full Text
AUTORES: Amadori, S; Suciu, S; Salih, H; Selleslag, D; Muus, P; De Fabritiis, P; Venditti, A; Ho, A; Lubbert, M; Thomas, X; Latagliata, R; Halkes, C; Falzetti, F; Magro, D; Guimaraes, JE; Berneman, Z; Specchia, G; Fazi, P; Vignetti, M; Karrasch, M; Willemze, R; De Witte, T; Marie, JP; ...Mais
PUBLICAÇÃO: 2012, FONTE: HAEMATOLOGICA, VOLUME: 97

INDEXADO EM:

WOS

Links Úteis